相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models
Rachid Skouta et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
The role of iron and reactive oxygen species in cell death
Scott J. Dixon et al.
NATURE CHEMICAL BIOLOGY (2014)
Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target
Luika A. Timmerman et al.
CANCER CELL (2013)
The emerging role of the Nrf2-Keap1 signaling pathway in cancer
Melba C. Jaramillo et al.
GENES & DEVELOPMENT (2013)
Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib
Christophe Louandre et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
The ABCs of membrane transporters in health and disease (SLC series): Introduction
Matthias A. Hediger et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
Modulation of oxidative stress as an anticancer strategy
Chiara Gorrini et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Enhanced 4-Hydroxynonenal Resistance in KEAP1 Silenced Human Colon Cancer Cells
Kyeong-Ah Jung et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
The oxidative stress-inducible cystine/glutamate antiporter, system xc-: cystine supplier and beyond
Marcus Conrad et al.
AMINO ACIDS (2012)
Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles
Abena S. Agyeman et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Mammalian proapoptotic factor ChaC1 and its homologues function as γ-glutamyl cyclotransferases acting specifically on glutathione
Akhilesh Kumar et al.
EMBO REPORTS (2012)
Halogen-Enriched Fragment Libraries as Leads for Drug Rescue of Mutant p53
Rainer Wilcken et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Sorafenib-Induced Hepatocellular Carcinoma Cell Death Depends on Reactive Oxygen Species Production In Vitro and In Vivo
Romain Coriat et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Data-Driven Prediction of Drug Effects and Interactions
Nicholas P. Tatonetti et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell
Toshifumi Yae et al.
NATURE COMMUNICATIONS (2012)
Sorafenib induces apoptotic cell death in human non-small cell lung cancer cells by down-regulating mammalian target of rapamycin (mTOR)-dependent survivin expression
Young-Sun Kim et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Inhibition of xc- transporter-mediated cystine uptake by sulfasalazine analogs
Krupa Shukla et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc- and Thereby Promotes Tumor Growth
Takatsugu Ishimoto et al.
CANCER CELL (2011)
Artesunate Activates Mitochondrial Apoptosis in Breast Cancer Cells via Iron-catalyzed Lysosomal Reactive Oxygen Species Production
Anne Hamacher-Brady et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Loss of System xc- Does Not Induce Oxidative Stress But Decreases Extracellular Glutamate in Hippocampus and Influences Spatial Working Memory and Limbic Seizure Susceptibility
Dimitri De Bundel et al.
JOURNAL OF NEUROSCIENCE (2011)
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
Theonie Anastassiadis et al.
NATURE BIOTECHNOLOGY (2011)
Glutamate release by primary brain tumors induces epileptic activity
Susan C. Buckingham et al.
NATURE MEDICINE (2011)
Plasma L-Cystine/L-Glutamate Imbalance Increases Tumor Necrosis Factor-Alpha from CD14+Circulating Monocytes in Patients with Advanced Cirrhosis
Eiji Kakazu et al.
PLOS ONE (2011)
Modulatory profiling identifies mechanisms of small molecule-induced cell death
Adam J. Wolpaw et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Privileged scaffolds for library design and drug discovery
Matthew E. Welsch et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation
Cole Trapnell et al.
NATURE BIOTECHNOLOGY (2010)
ATF4 is necessary and sufficient for ER stress-induced upregulation of REDD1 expression
Michael L. Whitney et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
TopHat: discovering splice junctions with RNA-Seq
Cole Trapnell et al.
BIOINFORMATICS (2009)
GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eran Eden et al.
BMC BIOINFORMATICS (2009)
Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults
Pierre A. Robe et al.
BMC CANCER (2009)
Sorafenib inhibits ERK1/2 and MCL-1L phosphorylation levels resulting in caspase-independent cell death in malignant pleural mesothelioma
Sharyn I. Katz et al.
CANCER BIOLOGY & THERAPY (2009)
CHAC1/MGC4504 Is a Novel Proapoptotic Component of the Unfolded Protein Response, Downstream of the ATF4-ATF3-CHOP Cascade
Imran N. Mungrue et al.
JOURNAL OF IMMUNOLOGY (2009)
Spheroid-based drug screen: considerations and practical approach
Juergen Friedrich et al.
NATURE PROTOCOLS (2009)
Quantitative signal detection using spontaneous ADR reporting
A. Bate et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
Scott M. Wilhelm et al.
MOLECULAR CANCER THERAPEUTICS (2008)
HepG2/C3A cells respond to cysteine deprivation by induction of the amino acid deprivation/integrated stress response pathway
Jeong-In Lee et al.
PHYSIOLOGICAL GENOMICS (2008)
The cystine/cysteine cycle:: a redox cycle regulating susceptibility versus resistance to cell death
A. Banjac et al.
ONCOGENE (2008)
The kinase inhibitor sorafenib induces cell death through a process involving induction of endoplasmic reticulum stress
Mohamed Rahmani et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels
Nicholas Yagoda et al.
NATURE (2007)
Chemoinformatics analysis identifies cytotoxic compounds susceptible to chemoresistance mediated by glutathione and cystine/glutamate transport system xc-
Zunyan Dai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Scott Wilhelm et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate
Dunyaporn Trachootham et al.
CANCER CELL (2006)
Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids
Peter S. Gargalovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Induction of AKR1C2 by phase II inducers:: Identification of a distal consensus antioxidant response element regulated by NRF2
H Lou et al.
MOLECULAR PHARMACOLOGY (2006)
被撤回的出版物: The Raf inhibitor BAY 43-9006 (Sorafenib) induces caspase-independent apoptosis in melanoma cells (Retracted article. See vol. 79, pg. 5459, 2019)
DJ Panka et al.
CANCER RESEARCH (2006)
Redox imbalance in cystine/glutamate transporter-deficient mice
H Sato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation
M Rahmani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Slc7a11 gene controls production of pheomelanin pigment and proliferation of cultured cells
S Chintala et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours
A Awada et al.
BRITISH JOURNAL OF CANCER (2005)
Phase I clinical and pharmacokinetic study of the novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors
D Strumberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
PTC Wan et al.
CELL (2004)
Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress response
HY Jiang et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Short interfering RNA-mediated silencing of glutaredoxin 2 increases the sensitivity of HeLa cells toward doxorubicin and phenylarsine oxide
CH Lillig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Role of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell lines
S Okuno et al.
BRITISH JOURNAL OF CANCER (2003)
An integrated stress response regulates amino acid metabolism and resistance to oxidative stress
HP Harding et al.
MOLECULAR CELL (2003)
Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells
S Dolma et al.
CANCER CELL (2003)
Design and discovery of small molecules targeting Raf-1 kinase
TB Lowinger et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc- cystine transporter:: a new action for an old drug
PW Gout et al.
LEUKEMIA (2001)
The reactive oxygen species- and Michael acceptor-inducible human aldo-keto reductase AKR1C1 reduces the α,β-unsaturated aldehyde 4-hydroacy-2-nonenal to 1,4-dihydroxy-2-nonene
ME Burczynski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Multicellular resistance: a paradigm for clinical resistance?
B Desoize et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2000)
分享论文
